Skip to main content
Leica Biosystems Histology and Pathology Product Innovation

创新是我们的 DNA

150 多年来,我们致力于应对病理学挑战,从更好的载玻片生产到支持 AI 开发的世界领先数字化病理学。我们的专家充满激情地推进癌症诊断、改善生活的使命。

Alternative text here Alternative text here

Introducing our New Staining and Glass Coverslipping Workstation, the HistoCore CHROMAX WS

Enter a new era of streamlined primary staining and coverslipping:

  • Increased productivity
  • Optimized reagent consumption
  • Modern graphical user interface

DISCOVER MORE 

For In Vitro Diagnostic Use.

集成解决方案。经过验证的性能。可靠的结果。

客户反馈

Image
Dr.-Eric-Peltier-260x440-2

感谢与 Leica 的紧密合作让我们可以使用最高质量的仪器。 整个方案都围绕着质量、可追溯性和连通性…… 它是依靠病理学家的专业知识进行创新和发展的基础。我们还想开发与此基础相关的其他技术。因此,它可以是基于人工智能的数字化病理学技术。

Translated from source language.

Eric Peltier 医生
Président Directeur Général - PRAXEA-DIAGNOSTICS

Image
Dr-Sylvia-L-Asa-MD-PhD-260x440

"Leica Biosystems 的产品可靠、优质,并且公司对于将传统病理学向数字化、互联式转变所需地条件有非常务实的认识。我知道我可以依靠他们,并相信他们现在和将来都会支持我。"

Translated from source language.

Sylvia L. Asa 医生,MD,PhD
克利夫兰大学医院医学中心内分泌病理学顾问

新闻和促销

Leica Biosystems launches HistoCore CHROMAX Workstation

Leave tedious manual process steps behind and enter a new era of streamlined primary staining and coverslipping.

This HistoCore CHROMAX WS allows your team to focus on what truly matters, accurate and timely specimen preparation.

For In Vitro Diagnostic Use.

Learn More

With over 25 years of Digital Pathology innovation, Leica Biosystems delivers performance and reliability.

Aperio GT 450 Scanner – Leading Innovation with Proven Technology

The Aperio GT 450 scanner offers state-of-the-art enhancements, including Manual Scan capabilities, DICOM compatible files, Extended Focus for composite in-focus images, and Aperio iQC Software.

For research use only. Not for use in diagnostic procedures.

Learn More

Leica Biosystems Partners with AstraZeneca to Advance Computational Diagnostics

The partnership focuses on driving global adoption of quantitative diagnostics in non-small cell lung cancer. This collaboration leverages our digital pathology leadership to accelerate the advancement of computational pathology tools.

Learn More